20594 ⎘
Medicinal preparations containing inorganic active ingredients; Heavy metals; Compounds thereof Arsenic; Compounds thereof
SYNERGISTIC INTERACTIONS FOR IMPROVED CANCER TREATMENT
#2HIGH SURFACE-AREA LYOPHILIZED COMPOSITIONS COMPRISING ARSENIC FOR ORAL ADMINISTRATION IN PATIENTS
#3PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER
#4INHIBITORS OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE (PIN1), COMBINATIONS AND USES THEREOF
#5COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER CELLS BY INDUCTION OF CYTOTOXIC OXIDATIVE STRESS
#6TRADITIONAL CHINESE MEDICINE FOR TREATING HEMORRHOIDS
#7CANCER TREATMENT BY ARSENIC TRIOXIDE COMBINATION THERAPY
#8INHIBITORS OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE (PIN1), COMBINATIONS AND USES THEREOF
#9METHOD AND COMPOSITION FOR RESTORING HOMEOSTASIS, TREATING, AND PREVENTING DEGENERATIVE DISEASES, ACHIEVING ANTI-AGING EFFECT
#10PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER
#11METHODS FOR TREATING AORTIC VALVE STENOSIS WITH A HEDGEHOG PATHWAY INHIBITOR
#12Use of an arsenic compound for treating a short or long cytokine storm in various autoimmune/inflammatory diseases in humans or animals
#13High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
#14Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
#15ORAL PHARMACEUTICAL COMPOSITION OF ARSENIC TRIOXIDE
#16SYSTEMS, DEVICES, AND METHODS FOR TREATING A PULMONARY DISORDER WITH AN AGENT
#17METHODS FOR INTRACELLULAR DELIVERY AND ENHANCED GENE TARGETING
#18High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
#19Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
#20PREVENTIVE OR THERAPEUTIC PHARMACEUTICAL COMPOSITION FOR CORONAVIRUS INFECTION COMPRISING TETRAARSENIC HEXOXIDE
#21Use of an arsenic compound for treating a short or long cytokine storm in various autoimmune/inflammatory diseases in humans or animals
#22STRUCTURALLY DEFINED, BETTER TOLERATED, ORALLY ADMINSTERED, PROCESSED ARSENOLITE, A PROCESS FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION AND USES THEREOF
#23METHOD OF TREATMENT USING META-ARSENITE
#24SYSTEMS, DEVICES, AND METHODS FOR TREATING A PULMONARY DISORDER WITH AN AGENT
#25COMPOUNDS FOR USE IN THE TREATMENT OF LEUKEMIA
#26Methods for treating pulmonary fibrosis with a hedgehog pathway inhibitor
#27COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES
#28Pharmaceutical formulation of arsenic trioxide
#29Use of metal ions to potentiate the therapeutic effects of arsenic
#30Pharmaceutical combination for the treatment of cancer
#31LOCALIZED DELIVERY OF THERAPEUTIC AGENTS
#32Enhanced Rodeferin Broad Spectrum
#33COMPOUNDS AND METHODS USEFUL FOR TREATING OR PREVENTING HEMATOLOGICAL CANCERS
#34Treatment and Prevention of Cardiovascular Disease
#35METHOD FOR PREPARING AND DELIVERING BISANTRENE FORMULATIONS
#36METHODS FOR TREATING AORTIC VALVE STENOSIS WITH A HEDGEHOG PATHWAY INHIBITOR
#37NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS
#38Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis
#39MP53 RESCUE COMPONDS AND METHODS OF TREATING A P53 DISORDER
#40Compositions and methods for the treatment of cancer cells by induction of cytotoxic oxidative stress
#41Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis
#42Use of water-soluble realgar solid dispersion in preparation of erythroid differentiation inducer for bone marrow hematopoietic stem cells and/or bone marrow hematopoietic progenitor cells
#43METHODS OF TREATING MINIMAL RESIDUAL CANCER
#44High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
#45Treatment and prevention of cardiovascular disease
#46Pharmaceutical composition comprising meta arsenite and method of manufacture
#47COMPOSITE ANTI-RESTENOSIS DRUG FOR CORONARY DRUG-ELUTING STENT AND CONTROLLED RELEASE SYSTEM THEREOF
#48Combination therapy for treatment of leukemia
#49Pharmaceutical combinations of organo-arsenoxide compounds and mTOR inhibitors
#50ACUTE AND CHRONIC MITOCHONDRIAL ELECTRON TRANSPORT CHAIN DYSFUNCTION TREATMENTS AND GRAPHENIC MATERIALS FOR USE THEREOF
#51Stable, highly pure L-cysteine compositions for injection and methods of use
#52NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS
#53Betaine for the prevention of obesity
#54Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the CNS
#55Reducing systemic regulatory T cell levels or activity for treatment of a retinal degeneration disorder
#56Pharmaceutical combination for the treatment of cancer
#57Pharmaceutical composition for treating liver cancer, comprising tetraarsenic hexoxide crystalline polymorph
#58High surface-area lyophilized compositions comprising arsenic for oral administration in patients
#59Arsenic compositions
#60PHARMACEUTICAL COMPOSITION FOR TREATING LEUKEMIA AND METHOD FOR PREPARING THE SAME
#61Pharmaceutical composition for preventing or treating cancer, comprising tetraarsenic hexoxide crystalline polymorph
#62Methods for treating aortic valve stenosis with a hedgehog pathway inhibitor
#63METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT PATIENTS SUFFERING FROM MYELOPROLIFERATIVE DISORDERS
#64Methods for intracellular delivery and enhanced gene targeting
#65Pharmaceutical composition for preventing or treating breast cancer including crystalline polymorph of tetraarsenic hexoxide, and method for producing same
#66Pharmaceutical composition for preventing or treating brain cancer including crystal polymorph of tetraarsenic hexoxide, and method for preparing same
#67Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#68Use of low dose arsenic for preserving genomic integrity
#69Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#70Combinations of LSD1 inhibitors for the treatment of hematological malignancies
#71High surface-area lyophilized compositions comprising arsenic for oral administration in patients
#72Pharmaceutical composition for treating leukemia and preparation method thereof
#73Method of treating relapsing-remitting multiple sclerosis using arsenic trioxide
#74Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the H2O2 level in cancer cells of a subject
#75Compounds and methods useful for treating or preventing hematological cancers
#76Treatment of autoimmune and inflammatory diseases with the arsenic compounds AS2O3 and/or AS2O5 administered locally
#77Arsenic trioxide for treatment of PIN1-associated disorders
#78Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
#79Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#80Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
#81Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
#82Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
#83METHOD AND COMPOSITIONS FOR TREATMENT OF CANCER
#84Compositions containing arsenic and their use in methods of treatment
#85XENON AND/OR ARGON TREATMENT AS AN ADJUNCT TO PSYCHOTHERAPY FOR PSYCHIATRIC DISORDERS
#86COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES
#87Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#88ANTI-CANCER EFFECTS OF PROTEASOME INHIBITORS IN COMBINATION WITH GLUCOCORTICOIDS, ARSENIC CONTAINING COMPOUNDS, AND ASCORBIC ACID
#89TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS
#90Anti-glycation methods and compositions
#91Pharmaceutical combination for the treatment of cancer
#92ANTI-ADDICTIVE COMPOSITION
#93Compositions, packaged pharmaceuticals, and methods of using hedgehog pathway modulators for the sensitization of resistant tumors
#94Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#95COMPOSITIONS AND METHODS FOR INDUCING DIFFERENTIATION OF STEM CELLS
#96Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
#97Combination of an arsenic compound and at least one retinoid for treating acute myeloid leukemia
#98Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancer
#99Combined application of isothiocyanate compound and anti-cancer medicine
#100MARKERS FOR LIPID METABOLISM
#101High surface-area lyophilized compositions comprising arsenic for oral administration in patients
#102Pharmaceutical compositions comprising sodium meta arsenite for treatment of multiple myeloma
#103Drinking water formulation and method and article relating to same
#104Dendrogenin A and antineoplastic agents for the treatment of chemosensitive or chemoresistant tumors
#105ARSENIC-BASED TREATMENT OF CANCERS AND INFLAMMATORY DISORDERS
#106MODEL OF ALZHEIMER'S DISEASE
#107Systems, devices, and methods for treating a pulmonary disorder with an agent
#108METHODS FOR TREATING CANCER
#109Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#110Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#111Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disorders
#112METHOD FOR THE EFFICIENT AND CONTINUOUS GROWTH AND HARVESTING OF NUTRIENT-RICH PHYTOPLANKTON AND METHODS OF USING THE SAME
#113Compositions and methods for the treatment of cancers
#114METHOD AND COMPOSITION FOR TREATING CANCER
#115TRADITIONAL CHINESE MEDICINE COMPOUND ANTITUMOR NANO PREPARATION AND USE THEREOF
#116TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS
#117Composition for preventing or treating immune-related disease and oxidative-stress-related disease
#118Arsenic compound solution and albumin nanoparticle and lyophilized preparation entrapping arsenic compound prepared using same
#119Methods, pharmaceutical compositions and kits for use in the treatment of adult T-cell leukemia/lymphoma
#120METHOD OF TREATING PATHOLOGIC HETEROTOPIC OSSIFICATION
#121Compositions and Methods for Detecting, Treating, or Preventing Reductive Stress
#122Method for the treatment of tuberculosis
#123Thioxanthone-based autophagy inhibitor therapies to treat cancer
#124Process for the preparation of a metal complex in an oily organic matrix
#125CO-ADMINISTRATION OF ARSENIC COMPOUNDS AND ANTI-HERPES VIRUS ANTI-VIRALS
#126Use of arsenic compounds for treatment of pain and inflammation
#127MODULATION OF HISTONE H2B MONOUBIQUITINATION AND TREATMENT OF CANCER
#128Method of treating cancer using combination of a bifunctional alkylating agent and DNA repair inhibitors
#129Novel IDO Inhibitors and Methods of Use Thereof
#130POTENTIATION INDUCED BY PDE4 INHIBITORS IN THE TREATMENT OF LEUKEMIA
#131Treatment for Concussion using Gallium Compounds
#132Drinking water formulation and method and article relating to same
#133Methods, pharmaceutical compositions and kits for use in the treatment of adult T-cell leukemia/lymphoma
#134Use of arsenic for cancer therapy protection
#135KIT FOR CANCER TREATMENT AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT
#136COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
#137METHOD AND COMPOSITION FOR TREATING CANCER
#138SYNTHESIS AND USE OF THERAPEUTIC METAL ION CONTAINING POLYMERIC PARTICLES
#139COMPOSITIONS AND METHODS FOR DETECTING, TREATING, OR PREVENTING REDUCTIVE STRESS
#140Treatment of retroviral reservoirs exploiting oxidative stress
#141Thioxanthone-based autophagy inhibitor therapies to treat cancer
#142Enhancement of the Anti-Leukemic Effect of Thalidomide
#143Compositions and methods relating to prevention of chemotherapy-induced alopecia
#144COMPOSITION FOR IMPROVING RADIOTHERAPY FOR CANCER
#145Use of arsenic for cancer therapy protection
#146Treatment of Inflammatory Conditions and Diseases with Metal-Thiols
#147TREATMENT OF ADENOCARCINOMA EXPRESSING LKB1 WITH MTOR INHIBITOR IN COMBINATION WITH COX2 INHIBITOR
#148Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
#149METHODS FOR TREATING BRAIN TUMORS
#150CANCER STEM CELL-TARGETED AND DRUG RESISTANT CANCER THERAPY
#151NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS
#152INDAZOLE INHIBITORS OF TYROSINE KINASE
#153Method for the efficient and continuous growth and harvesting of nutrient-rich phytoplankton and methods of using the same
#154PODOPHYLLOTOXIN INHIBITORS OF TOPOISOMERASE II
#155STEROID MODULATORS OF PROGESTERONE RECEPTOR AND/OR GLUCOCORTICOID RECEPTOR
#156HEDGEHOG SIGNALING AND CANCER STEM CELLS IN HEMATOPOIETIC CELL MALIGNANCIES
#157IDO inhibitors and methods of use thereof
#158Selective Targeting of Apoptotic Cells
#159Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
#160METHOD AND COMPOSITIONS FOR TREATMENT OF CANCER
#161Anti-glycation methods and compositions
#162PHARMACEUTICAL COMPOSITION, PROCESS FOR MANUFACTURING THE SAME AND ITS MEDICAL DEVICE FOR THE TREATMENT OF CUTANEOUS LESIONS
#163COMBINATION OF A SEROTONIN REUPTAKE INHIBITOR AND A 5-HT2C ANTAGONIST, INVERSE AGONIST OR PARTIAL AGONIST
#164Acidic composition
#165Sodium alginate microsphere vascular embolus containing water-soluble drug and preparation and application thereof
#166Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies
#167KIT FOR CANCER TREATMENT AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT
#168Arsenic therapy for APLS-type autoimmune lymph-oproliferative syndrome in mice and humans
#169PHARMACEUTICAL COMPOSITIONS COMPRISING OF ARSENOUS ACID, ITS SODIUM SALT AND ITS DERIVATIVES INTENDED FOR THE TREATMENT OR UROGENITAL CANCER AND ITS METASTASIS
#170Compositions of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer
#171METHOD AND COMPOSITION FOR TREATING CANCER
#172Compositions and methods relating to prevention of chemotherapy-induced alopecia
#173Application of arsenic as a cancer prevention agent
#174Use of arsenic compounds for treatment of pain and inflammation
#175Polyoxometalate materials, metal-containing materials, and methods of use thereof
#176METHOD FOR INHIBITING CANCER USING ARSENIC TRIOXIDE
#177Method for Inhibiting Cancer Using Arsenic Trioxide
#178Method for treating cancer using oral arsenic trioxide
#179Method for inhibiting cancer using arsenic trioxide
#180Antifungal compositions and method
#181Method of Treating Cancer Using Dithiocarbamate Derivatives
#182Methods of treating hematological malignancies
#183Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer
#184COMBINATION OF A SEROTONIN REUPTAKE INHIBITOR AND A 5-HT2C ANTAGONIST, INVERSE AGONIST OR PARTIAL AGONIST
#185Compositions and methods for cancer treatment
#186Stable microemulsion concentrate for delivery of a bioactive biocide/disinfectant/fungicide/fragrance in an aqueous medium providing sustained release
#187Encapsulated arsenic drugs
#188Arsenic compounds for the treatment of the arsenic-sensitive blast-cell related diseases
#189Methods and compositions for augmenting cancer chemotherapeutic agents
#190Antiseptic solutions containing silver chelated with polypectate and EDTA
#191Compositions and methods for destabilizing lysosomes to increase oncogenic or aberrant protein degradation
#192Doped metal oxide nanoparticles and methods for making and using same
#193Pharmaceutical preparation
#194Method and topical formulation for treating headaches
#195Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
#196Use of arsenic-containing pharmaceutical composition in combination with radiation therapy for cancer treatment
#197Method and pharmaceutical composition for treatment of skin neoplasm
#198Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
#199Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans
#200Pharmaceutical composition comprising arsenite for the treatment of malignancy
#201Selective targeting of apoptotic cells
#202Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
#203Method of treating cancer using dithiocarbamate derivatives
#204Herbo-mineral formulation for refractory leukemias and lymphomas
#205Application of arsenic as a cancer and heart disease prevention agent
#206Immunopotentiators in thermotherapy for cancer
#207Stable, highly pure L-cysteine compositions for injection and methods of use
#208Stable, highly pure L-cysteine compositions for injection and methods of use
#209Stable, highly pure L-cysteine compositions for injection and methods of use
#210Stable, highly pure L-cysteine compositions for injection and methods of use
#211Stable, highly pure L-cysteine compositions for injection and methods of use
#212Stable, highly pure L-cysteine compositions for injection and methods of use
#213Stable, highly pure L-cysteine compositions for injection and methods of use
#214Stable, highly pure L-cysteine compositions for injection and methods of use
#215Stable, highly pure L-cysteine compositions for injection and methods of use
#216Stable, highly pure l-cysteine compositions for injection and methods of use
#217Stable, highly pure L-cysteine compositions for injection and methods of use
#218Enhanced Rodeferin broad spectrum
#219Stable, highly pure L-cysteine compositions for injection and methods of use
#220Stable, highly pure L-cysteine compositions for injection and methods of use
#221Stable, highly pure L-cysteine compositions for injection and methods of use
#222Stable, highly pure L-cysteine compositions for injection and methods of use
#223Stable, highly pure L-cysteine compositions for injection and methods of use
#224Method for cancer treatment
#225Method for prevention and treatment of cancer, tuberculosis and related diseases